MarketInOut Stock Screener Log In | Sign Up

Anteris Technologies Global Corp

Healthcare • Medical Devices • Quote as of 10/29/2026 15:50
Anteris Technologies Global Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
Market Capitalization800.15 mln
Float97.34 mln
Earnings Date11/12/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-5.07
Highly reliable

Relative Strength

35 / 100
Underperforming

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-4,568%
Severely loss-making

ROE

-92.83
Deeply negative

Business Description

Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through less invasive surgical approaches. Its flagship product, the DurAVR system, uses a catheter-based method to replace damaged aortic valves with a design that closely replicates the natural function of a healthy heart valve. The company also works with specialized tissue treatments and delivery tools that help surgeons operate with greater precision while reducing the risk of complications. Anteris is headquartered in Toowong, Australia.

Key Fundamentals

EPS-2.88
ROE-92.83
RPS0.04
ROIC-718
ROA-79.59
Interest Cover-12,805
EBITDA, mln-148
EV / EBITDA-4.83
EV / EBIT-4.75
Revenue, mln3.26
EV / Revenue216

Quote Details

Last 8.55
Change 0.1 (1.18%)
Open 8.40
Volume 16,246
Turnover 138,903
Average Volume 6,048.52

Financial Ratios

Pre-Tax Profit Margin-4,568
Leverage Ratio1.08
Current Ratio14.20
Price / Book2.89
Price / Tangible Book2.94
Debt / Equity0.01
Price / Sales207

Financial Strength

Altman Z-Score18.97
Piotroski F-Score 4 / 9
Beneish M-Score-5.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.81% 37 / 100   
1 Month -20.61% 16 / 100   
2 Months -27.54% 15 / 100   
6 Months 4.91% 73 / 100   
1 Year -2.84% 54 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog